We are live on
!
Find out more
HCM
Howland Capital Management Portfolio holdings
AUM
$2.77B
1-Year Est. Return
19.56%
This Fund
S&P 500
This Quarter
Est. Return
-0.84%
1 Year Est. Return
+19.56%
3 Year Est. Return
+72.01%
5 Year Est. Return
+82.45%
10 Year Est. Return
+296.19%
AUM
$2.28B
AUM Growth
-$23.4M
(-1%)
Cap. Flow
+$16.7M
Cap. Flow
% of AUM
0.73%
Top 10 Holdings %
Top 10 Hldgs %
37.62%
Holding
296
New
19
Increased
89
Reduced
112
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$11.9M |
| 2 |
iShares iBonds Dec 2028 Term Corporate ETF
IBDT
|
+$5.16M |
| 3 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$3.97M |
| 4 |
iShares iBonds Dec 2027 Term Corporate ETF
IBDS
|
+$3.8M |
| 5 |
iShares iBonds Dec 2026 Term Corporate ETF
IBDR
|
+$3.49M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBDP
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
|
+$14.3M |
| 2 |
Johnson & Johnson
JNJ
|
+$4.63M |
| 3 |
Chevron
CVX
|
+$3.68M |
| 4 |
Constellation Brands
STZ
|
+$3.36M |
| 5 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$2.31M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.56% |
| 2 | Financials | 13.62% |
| 3 | Healthcare | 8.75% |
| 4 | Communication Services | 7.94% |
| 5 | Consumer Discretionary | 7.1% |
Similar funds
EGA
GM
SAM
LGP
NSLI
JFGIW
TMAM
MC
Howland Capital Management's Q4 2024 Portfolio in Review
As of Q4 2024, Howland Capital Management held 296 positions worth $2.28B, down 1% from $2.31B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Howland Capital Management's Q4 2024 filing shows 19 new, 89 increased, 112 reduced and 13 closed positions. Its largest new stake was Cintas: 9,220 shares worth $1.68M. The largest sale was iShares iBonds Dec 2024 Term Corporate ETF, an estimated $14.3M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- Howland Capital Management's largest Q4 2024 buy was Cintas: 9,220 shares worth $1.68M.
- Howland Capital Management added most to Regeneron Pharmaceuticals in Q4 2024, an estimated $11.9M increase.
- Howland Capital Management's biggest Q4 2024 reduction was Johnson & Johnson, cutting an estimated $4.63M.
- Howland Capital Management fully exited iShares iBonds Dec 2024 Term Corporate ETF in Q4 2024, selling an estimated $14.3M.
- Howland Capital Management's ten largest holdings make up 38% of its $2.28B portfolio in Q4 2024.
- Howland Capital Management opened 19 new positions and closed 13 in Q4 2024.
- Howland Capital Management's portfolio value fell 1% quarter-over-quarter to $2.28B.
Based on Howland Capital Management's 13F filing for Q4 2024, filed 28 Jan 2025.